Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP

被引：0
|
作者：
Proctor, B. R. [1 ]
Hui, D. [1 ]
Donaldson, J. [1 ]
Savage, K. J. [1 ]
Shenkier, T. N. [1 ]
Hoskins, P. J. [1 ]
Klasa, R. [1 ]
Randy, G. [1 ]
Joseph, C. [1 ]
Sehn, L. H. [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.8583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8583
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy
    Mitsuhashi, Kenjiro
    Masuda, Akihiro
    Wang, Yan-Hua
    Shiseki, Masayuki
    Motoji, Toshiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (01) : 88 - 95
  • [12] Prognostic Significance Of Systemic Inflammatory Factors In Patients With Diffuse Large B Cell Lymphoma Treated By R-CHOP
    Yoh, Kyung Ah
    Lee, Ho Sup
    Park, Lee Chun
    Lee, Eun Mi
    Shin, Seong Hoon
    Ye, Byeong Jin
    Moon, Joon Ho
    Jo, Jae-Cheol
    Lee, Won Sik
    Shin, Ho-Jin
    Oh, Sun Young
    Kim, Yang Soo
    BLOOD, 2013, 122 (21)
  • [13] Prognostic Impact of Tumor Microenvironment on Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Gomez-Gelvez, J. C.
    Salama, M.
    Cogan, C.
    Leavitt, M.
    Inamdar, K.
    LABORATORY INVESTIGATION, 2013, 93 : 329A - 329A
  • [14] Prognostic Impact of Tumor Microenvironment on Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Gomez-Gelvez, J. C.
    Salama, M.
    Cogan, C.
    Leavitt, M.
    Inamdar, K.
    MODERN PATHOLOGY, 2013, 26 : 329A - 329A
  • [15] R-IPI as a predictor of survival in patients with diffuse large cell B-cell lymphoma (DLBCL) treated with R-chop chemotherapy
    Siddiqui, M.
    Johnston, P. B.
    Micallef, I. N.
    Ansell, S. M.
    Colgan, J. P.
    Habermann, T. M.
    Inwards, D. J.
    Markovic, S. N.
    Ristow, K.
    Witzig, T. E.
    Porrata, L. F.
    ANNALS OF ONCOLOGY, 2008, 19 : 146 - 146
  • [16] Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
    Nyman, Heidi
    Jerkeman, Mats
    Karjalainen-Lindsberg, Marja-Liisa
    Banham, Alison H.
    Leppa, Sirpa
    MODERN PATHOLOGY, 2009, 22 (08) : 1094 - 1101
  • [17] Primary Cutaneous Diffuse Large B-cell Lymphoma Successfully Treated With R-CHOP Chemotherapy
    Alghamdi, Wafa M.
    Aljehani, Fawaz H.
    Alharthi, Abdullah M.
    Bakhsh, Reda I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [18] Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
    Kim, Moonho
    Ahn, Yongchel
    Ahn, Heui-June
    Ha, Suk-Hun
    Oh, Ho-Suk
    Song, Jae-Seok
    Park, Woong-Sub
    Yi, Sang-Wook
    ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3167 - 3175
  • [19] Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
    Moonho Kim
    Yongchel Ahn
    Heui-June Ahn
    Suk-Hun Ha
    Ho-Suk Oh
    Jae-Seok Song
    Woong-Sub Park
    Sang-Wook Yi
    Annals of Hematology, 2023, 102 : 3167 - 3175
  • [20] Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
    Liu, Zhiyu
    Xu-Monette, Zijun Y.
    Cao, Xin
    Visco, Carlo
    Tzankov, Alexander
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Huh, Jooryung
    Ai, Weiyun
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Farnen, John P.
    Moller, Michael B.
    Winter, Jane N.
    Piris, Miguel A.
    Medeiros, L. Jeffrey
    Young, Ken H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S216 - S216
12345